Liu De Gong - Net Worth and Insider Trading
Liu De Gong Net Worth
The estimated net worth of Liu De Gong is at least $6 Million dollars as of 2024-11-08. Liu De Gong is the Supervisors of Tibet Rhodiola Pharmaceutical Holding Co and owns about 140,140 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) stock worth over $6 Million. Details can be seen in Liu De Gong's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Liu De Gong has not made any transactions after 2008-01-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Liu De Gong
Liu De Gong Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Liu De Gong owns 1 companies in total, including Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) .
Click here to see the complete history of Liu De Gong’s form 4 insider trades.
Insider Ownership Summary of Liu De Gong
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | Supervisors |
Liu De Gong Latest Holdings Summary
Liu De Gong currently owns a total of 1 stock. Liu De Gong owns 140,140 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) as of January 25, 2008, with a value of $6 Million.
Latest Holdings of Liu De Gong
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | 140,140 | 40.14 | 5,625,220 |
Holding Weightings of Liu De Gong
Liu De Gong Form 4 Trading Tracker
According to the SEC Form 4 filings, Liu De Gong has made a total of 0 transactions in Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) over the past 5 years. The most-recent trade in Tibet Rhodiola Pharmaceutical Holding Co is the sale of 140,140 shares on January 25, 2008, which brought Liu De Gong around $390,040.
Insider Trading History of Liu De Gong
- 1
Liu De Gong Trading Performance
GuruFocus tracks the stock performance after each of Liu De Gong's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Liu De Gong is -40%. GuruFocus also compares Liu De Gong's trading performance to market benchmark return within the same time period. The performance of stocks bought by Liu De Gong within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Liu De Gong's insider trading performs compared to the benchmark.
Performance of Liu De Gong
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.85 | | | | | |
| Relative Return to S&P 500(%) | 2.75 | | | | | |
Liu De Gong Ownership Network
Ownership Network List of Liu De Gong
Ownership Network Relation of Liu De Gong
Liu De Gong Owned Company Details
What does Tibet Rhodiola Pharmaceutical Holding Co do?
Who are the key executives at Tibet Rhodiola Pharmaceutical Holding Co?
Liu De Gong is the Supervisors of Tibet Rhodiola Pharmaceutical Holding Co. Other key executives at Tibet Rhodiola Pharmaceutical Holding Co include senior management Wang Bao Ming , senior management Cao Shu Zhen , and Supervisors Ren Bei Chen .
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tibet Rhodiola Pharmaceutical Holding Co Insider Transactions
Liu De Gong Mailing Address
Above is the net worth, insider trading, and ownership report for Liu De Gong. Currently GuruFocus does not have mailing address information for Liu De Gong.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
